蛛网膜下腔出血（以下简称SAH）为临床常见脑血管病，发病率约为对八0万L‘］，其继发癫病的临床报道较多，但发病率各家报道不一，约10－20％左右。由于继发癫痛，SAH病人死亡率较未继发癫痛者大大增加一2］，为了迅速控制癫痛减少SAH病人死亡率，我们采用苯妥奖销辅以尼莫地 Subarachnoid hemorrhage (hereinafter referred to as SAH) is a common clinical cerebrovascular disease, the incidence of about 80 million L ’], its clinical reports of epilepsy more, but the incidence of various reports vary, about About 10-20%. Due to secondary epilepsy, SAH patients mortality rate was significantly higher than those without secondary epilepsy [2], in order to quickly control the epilepsy reduce SAH mortality, we use phenytoin sales supplemented by nimodipine